Business Wire

ROBOSENSE

22.8.2019 16:57:11 CEST | Business Wire | Press release

Share
RoboSense and Aidrivers Announce a Partnership to Deliver Superior Autonomous Solutions for Industrial Transportation

RoboSense, the leading supplier of LiDAR perception system solutions, and Aidrivers, the UK's leading provider of autonomous mobility solutions for industrial applications announced today a partnership in system integration. Aidrivers will integrate RoboSense Smart LiDAR Sensor System into their own Autonomous Driving Systems.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190822005468/en/

Aidrivers is delivering a fully autonomous natural navigation system that meets industrial safety standards to seaports, particularly for horizontal transportation, aimed for improving operation efficiency and leading the way in industrial autonomous mobility automation. Their solution can work under all harsh weather conditions by achieving true 3D mapping and localization for precision positioning and situation cognisance and they are using RoboSense 3D LiDAR sensor technology, which collects stable and reliable environment information at near and far distance and under different weather conditions.

The performance of RoboSense 3D LiDAR products in harsh weather condition is impressive. We have been testing trailer vehicles under heavy rain and harsh weather conditions and our precision positioning system based on true 3D mapping and localization systems provides accurate localization result. The point cloud data quality in rainy days is excellent and outperforming state of the art.” Aidrivers founder and CEO Dr. Rafiq Swash said, “Aidrivers is dedicated to providing safer, reliable and high-quality Ai enabled autonomous mobility solutions for industrial transportation, and the partnership with RoboSense will give a great confidence to our end users that we are providing autonomous solutions which overcome current challenges of industrial horizontal transportation. Our Ai enabled autonomous solutions are now catering to more industrial transportation industries for both indoor and outdoor in complex environment and weather conditions.”

As one of the pioneer companies to commercialize autonomous driving technology in UK, Aidrivers has been favored by industry giants in the field of autonomous port automation. Aidrivers is deploying a fleet of autonomous prime movers for the world’s leading and busiest port terminals. Aidrivers and SANY have recently partnered to deliver autonomous electric vehicles, specifically industrial horizontal transport solutions, for the Chinese market.

Video about Aidrivers and SANY’s vehicle : https://twitter.com/aidriversltd/status/1141257250629177344?s=20

In these projects, the AI enabled autonomous mobility solutions provided by Aidrivers use RoboSense's 3D LiDARs to collect rich and reliable environment perception data, conduct real-time accurate 3D object detection and tracking. Aidrivers is leading the situation cognisance with AI enabled data fusion to deliver a safer and reliable autonomous driving solutions for complex trailer vehicles under harsh weather.

“Aidrivers is driving the commercialization of autonomous driving technology for industrial transportation on a global scale. RoboSense is very pleased to collaborate with Aidrivers to build safer and robust autonomous driving solutions for major port terminals, and push for the commercialization of this technology.” RoboSense Co-founder and COO, Mark said, “Through in-depth cooperation with Aidrivers, RoboSense will continue to explore and understand the needs of industrial automation, and together with our partners, we will optimize and launch more practical LiDAR perception systems from the application perspective.

RoboSense's LiDAR sensors, AI Perception Algorithms and Smart LiDAR Sensor System are widely used in various types of autonomous driving scenarios. Currently, RoboSenses partners covers the world's major autonomous driving technology companies, automotive OEMs, and Tier 1 suppliers. RoboSense has always striven to optimize product performance and reliability to help autonomous driving vehicles to better cope with harsh environments and extreme conditions.

For more information please visit https://aidrivers.ai/ and https://www.robosense.ai/

Social Media:

https://www.facebook.com/RoboSenseLiDAR/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Okomera Strengthens Its Leadership Team With the Appointment of Marion Ghibaudo as Chief Technology Officer16.9.2026 08:00:00 CEST | Press release

An expert in scaling medical innovations, Marion Ghibaudo joins Okomera as the company advances toward industrial deployment. Okomera, a TechBio company pioneering next-generation cancer care through the development of a proprietary technology platform combining tumor mini-avatars, microfluidics, and AI-powered imaging, today announced the appointment of Marion Ghibaudo as Chief Technology Officer. She will spearhead the company’s technology and innovation strategy and lead the industrial deployment of its integrated hardware, software, and biological platform. Marion Ghibaudo will join Okomera’s Executive Committee and report to CEO Silvère Lucquin. In parallel, Raphaël Tomasi, Okomera’s co-founder and former CTO, transitions to the role of VP Platform, ensuring continuity in the development of the company’s technology platform. Marion’s appointment comes at a key stage in Okomera’s growth as the company advances toward pilot studies, industrial scale-up, and commercialization. Okomer

Galderma’s Restylane® Volyme™ Demonstrates High Effectiveness, Satisfaction and a Robust Safety Profile in Chinese Patients With Temple Hollowing16.9.2026 07:00:00 CEST | Press release

Positive topline results showed that Restylane Volyme (known as Restylane Contour in the U.S.) was highly effective in the correction of moderate-to-severe temple hollowing, with high responder rates maintained through Month 121 Restylane Volyme was well tolerated, with no incidences of granulomas. Patient and investigator satisfaction were also high1 These data support Galderma’s aim to expand the availability of the Restylane portfolio in China – a market undergoing significant expansion, and further strengthen Restylane’s vast clinical evidence base2,3 Galderma (SIX: GALD) today announced positive topline results from a study of Restylane Volyme for the correction of moderate-to-severe temple hollowing in 162 patients in China.1 The study met its primary endpoint, demonstrating the effectiveness and safety of Restylane Volyme versus a no-treatment control, while also achieving high patient and investigator satisfaction.1 These data further reinforce Galderma's ambition to expand its

Nippon Electric Glass’s IR Transmitting Glass “FI-02” Adopted for Heimann Sensor Lens Unit, Enabling a 120° × 68° Field of View16.9.2026 03:00:00 CEST | Press release

Nippon Electric Glass Co., Ltd. (NEG) (TOKYO: 5214), a global leader in specialty glass headquartered in Otsu, Japan, announced that its IR Transmitting Glass (chalcogenide glass) “FI-02” has been adopted for Heimann Sensor GmbH’s wide-angle lens unit for thermal cameras. The lens unit achieves a 120° × 68° field of view, surpassing the previous product’s maximum of 92° × 59°. The adoption marks a significant milestone for FI-02 and showcases how advanced specialty glass can meet the demanding optical and manufacturing requirements of the expanding infrared sensing market. Thermal cameras detect infrared radiation emitted by people or objects and convert it into thermal images. Infrared sensors can detect the locations of people and temperature distributions. They are expected to be used for people detection and monitoring, where privacy considerations are important, and for air-conditioning control, while their use is expanding in healthcare, equipment monitoring, and security. Advanc

Workiva Advances Regulatory Work with AI Innovation15.9.2026 17:00:00 CEST | Press release

Agent Studio anchors AI capabilities unveiled at Amplify 2026 Workiva Inc. (NYSE: WK), a leading, audit-ready platform for trust, transparency, and accountability, unveiled dozens of new product and platform innovations at Amplify 2026, the company’s annual conference attended by thousands of finance, accounting, sustainability, risk, and compliance leaders. Workiva Debuts Agent Studio Workiva introduced Agent Studio, a landmark platform capability that empowers users to quickly build, customize, and deploy AI agents in Workiva's trusted platform. By combining AI reasoning with Workiva's native platform capabilities, enterprise knowledge, and governed workflows, Agent Studio enables users to automate sophisticated manual business processes without writing any code. Organizations can enrich agents with company-specific knowledge and context, tailor them to their own processes, and schedule automations to execute recurring work. “With Agent Studio, we're putting the power to build in the

Study: Heatwaves Increase Cough Urge, Which Salt Aerosols Reduce15.9.2026 15:15:00 CEST | Press release

New Study Indicates Non-Pharmacological Aerosol May Provide Therapeutic Relief for Respiratory Conditions Provoked by the Atmospheric Aridity Inherent to Heatwaves SC Therapeutics, with University North Carolina, Imperial College London, and Boston University, announced publication on Tuesday in Nature Scientific Reports of results from a multi-institutional study indicating that the aridity inherent in heatwaves increases cough hypersensitivity in human airways by collapsing mucus onto cilia in a manner common to chronic respiratory diseases, such as cystic fibrosis, and asthma. The researchers find that alkaline aerosols of magnesium salts reverse mucosal collapse for several hours, and reduce cough hypersensitivity as reflected in placebo-adjusted suppression of daily cough bout rate (59%, p=0.03) and persistence of suppression post treatment for 1 to 3 weeks in a randomized, double-blind, placebo-controlled study of 10 refractory chronic cough patients. “Paris recorded 5,764 excess

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye